Approval · Notice of Compliance 7673 · 2006
PMS-AZITHROMYCIN: Notice of Compliance 7673
Issued January 3, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7673
- Date
- January 3, 2006
- Company
- Pharmascience Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Antibiotic
- Canadian reference product
- ZITHROMAX (Pfizer Canada Ulc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PMS-AZITHROMYCIN | 02261634 | Marketed |
| PMS-AZITHROMYCIN | 02261642 | Dormant |
Medicinal ingredients
- AZITHROMYCIN 250 MG per TAB
- AZITHROMYCIN 600 MG per TAB